Zi-Yue He

Shengjiang San modification promotes colonic mucosal repair in ulcerative colitis rats by inhibiting lauric acid-Shigella synergistic damage via PKC signaling pathway.

OBJECTIVES Ulcerative colitis (UC) is a chronic, relapsing inflammatory bowel disease. Recent research has focused on microbial dysbiosis within the gut environment. Although Shengjiang San modification ameliorates inflammation via activation of the PKC signaling pathway, the specific molecular mechanisms underlying it...